Sfoglia per Rivista
Qualitative and quantitative polymerase chain reaction monitoring of minimal residual disease in relapsed chronic lymphocytic leukemia : early assessment can predict long-term outcome after reduced intensity allogeneic transplantation
2009 L. Farina, C. Carniti, A. Dodero, A. Vendramin, A. Raganato, F. Spina, F. Patriarca, F. Narni, F. Benedetti, A. Olivieri, P. Corradini
Quantitative analysis of repetitive elements methylation in B-cell chronic lymphocytic leukemia
2009 S. Fabris, V. Motta, V. Bollati, V. Pegoraro, G. Cutrona, L. Mosca, S. Matis, D. Ronchetti, M. Colombo, M. Gentile, M. Spriano, V. Callea, G. Festini, S. Molica, A. Cortelezzi, G. Lambertenghi Deliliers, F. Morabito, M. Ferrarini, P.A. Bertazzi, A. Baccarelli, A. Neri
Quantitative global methylation analysis of DNA repetitive sequences in B-cell chronic lymphocytic leukemia reveals a significant hypomethylation in patients with 17p deletion
2009 S. Fabris, V. Motta, V. Bollati, V. Pegoraro, G. Cutrona, L. Mosca, S. Matis, D. Ronchetti, M. Colombo, M. Gentile, M. Spriano, V. Callea, G. Festini, S. Molica, L. Baldini, A. Cortelezzi, G. Lambertenghi Deliliers, F. Morabito, M. Ferrarini, P.A. Bertazzi, A. Baccarelli, A. Neri
Randomized phase II trial of deferasirox (Exjade, ICL670), a once-daily, orally-administered iron chelator, in comparison to deferoxamine in thalassemia patients with transfusional iron overload
2006 A. Piga, R. Galanello, G.L. Forni, M.D. Cappellini, R. Origa, A. Zappu, G. Donato, E. Bordone, A. Lavagetto, L. Zanaboni, R. Sechaud, N. Hewson, J.M. Ford, H. Opitz, D. Alberti
Randomized trial of radiation-free central nervous system prophylaxis comparing intrathecal triple therapy with liposomal cytarabine in acute lymphoblastic leukemia
2015 R. Bassan, A. Masciulli, T. Intermesoli, E. Audisio, G. Rossi, E..M. Pogliani, V. Cassibba, D. Mattei, C. Romani, A. Cortelezzi, C. Corti, A..M. Scattolin, O. Spinelli, M. Tosi, M. Parolini, F. Marmont, E. Borlenghi, M. Fumagalli, S. Cortelazzo, A. Gallamini, R..M. Marfisi, E. Oldani, A. Rambaldi
A rapid clearance of minimal residual disease after allogeneic stem cell transplantation predicts the clinical outcome of high risk adult all patients
2007 O. Spinelli, B. Peruta, M. Tosi, V. Guerini, A. Salvi, M.C. Zanotti, E. Oldani, A. Grassi, T. Intermesoli, C. Micò, G. Rossi, P. Fabris, G. Lambertenghi Deliliers, E. Angelucci, T. Barbui, R. Bassan, A. Rambaldi
A rapid clearance of MRD after allogeneic stem cell transplantation predicts a favourable outcome in high risk adult all patients
2007 O. Spinelli, B. Peruta, M. Tosi, V. Guerini, A. Salvi, M.C. Zanotti, E. Oldani, A. Grassi, T. Intermesoli, C. Mico’, G. Rossi, P. Fabris, G.L.A.M.B.E.R.T.E.N.G.H. Deliliers, E. Angelucci, T. Barbui, R. Bassan, A. Rambaldi, G. LAMBERTENGHI DELILIERS
Rare variants lowering the levels of coagulation factor X are protective against ischemic heart disease
2020 E.M. Paraboschi, A.V. Khera, P.A. Merlini, L. Gigante, F. Peyvandi, M. Chaffin, M. Menegatti, F. Busti, D. Girelli, N. Martinelli, O. Olivieri, S. Kathiresan, D. Ardissino, R. Asselta, S. Duga
Reactive follicular hyperplasia during dasatinib treatment: an underestimated adverse event
2017 C. Bucelli, D. Cattaneo, N. Orofino, J.A. Giannotta, M. Zappa, L. Cro, U. Gianelli, A. Iurlo
Recommendations regarding splenectomy in hereditary hemolytic anemias
2017 A. Iolascon, I. Andolfo, W. Barcellini, F. Corcione, L. Garçon, L. De Franceschi, C. Pignata, G. Graziadei, D. Pospisilova, D.C. Rees, M. de Montalembert, S. Rivella, A. Gambale, R. Russo, L. Ribeiro, N. Jules Vives Corrons, P.A. Martinez, A. Kattamis, B. Gulbis, M.D. Cappellini, I. Roberts, H. Tamary
Reconstruction of transcriptional regulatory networks in multiple myeloma
2009 M. Forcato, F. Ferrari, L. Agnelli, K. Todoerti, L. Baldini, F. Morabito, V. Callea, A. Palumbo, G. Lambertenghi Deliliers, S. Bortoluzzi, S. Bicciato, A. Neri
Recurrent mutations identified on LMAN1 and coagulation factors VII, X, XIII genes
2008 A. Cairo, M. Menegatti, M. Spreafico, I. Garagiola, F. Peyvandi
Recurrent thrombosis in patients with antiphospholipid antibodies treated with vitamin K antagonists or rivaroxaban
2018 I. Martinelli, M. Abbattista, P. Bucciarelli, A. Tripodi, A. Artoni, F. Gianniello, C. Novembrino, F. Peyvandi
Recurrent thrombosis in patients with polycythemia vera and essential thrombocythemia : incidence, risk factors, and effect of treatments
2008 V. De Stefano, T. Za, E. Rossi, A.M. Vannucchi, M. Ruggeri, E. Elli, C. Micò, A. Tieghi, R.R. Cacciola, C. Santoro, G. Gerli, N. Vianelli, P. Guglielmelli, L. Pieri, F. Scognamiglio, F. Rodeghiero, E.M. Pogliani, G. Finazzi, L. Gugliotta, R. Marchioli, G.
Reduced 25-OH vitamin D levels in patients with autoimmune citopenias: correlation with haematological parameters and clinical severity
2014 B. Fattizzo, A. Zaninoni, F. Nesa, B. Motta, A. Cortelezzi, W. Barcellini
Reduced expression of toll-like receptor 4 in B-chronic lymphocytic leukemia patients with autoimmune complications
2013 W. Barcellin, B. Fattizzo, F. Imperiali, A. Zaninoni, S. Lonati, G. Reda, A. Cortelezzi
Reduced intensity conditioning allogeneic transplant for advanced chronic lymphocytic leukemia
2004 D. Soligo, M. Motta, C. Borsotti, A. Ibatici, A. Cortelezzi, G. Lambertenghi Deliliers
Reduced intensity stem cell transplantation for advanced soft tissue sarcomas in adults : a retrospective analysis of the European Group for Blood and Marrow Transplantation
2007 S. Secondino, M.G. Carrabba, P. Pedrazzoli, L. Castagna, F. Spina, F. Grosso, A. Bertuzzi, J.O. Bay, S. Siena, P. Corradini, D. Niederwieser, T. Demirer, European Group for Blood, Marrow Transplantation Solid Tumors Working Party
Reduced-intensity conditioning allogeneic hematopoietic stem cell transplantation in advanced stage mycosis fungoides and sezary syndrome : long-term results from a single-institution phase II study
2011 F. Onida, E. Tagliaferri, C. Annaloro, G. Saporiti, L. Corli, P. Vezzoli, P. Usardi, G. Lambertenghi Deliliers, A. Cortelezzi, E. Berti
Reduction in liver iron concentration is consistent across subgroups of non-transfusion-dependent thalassemia patients treated with deferasirox : results from the 1-year thalassa study
2012 A. Taher, J. Porter, V. Viprakasit, A. Kattamis, S. Chuncharunee, P. Sutcharitchan, N. Siritanaratkul, R. Galanello, Z. Karakas, T. Lawniczek, D. Habr, J. Ros, Y. Zhang, D. Cappellini
Legenda icone
- file ad accesso aperto
- file disponibili sulla rete interna
- file disponibili agli utenti autorizzati
- file disponibili solo agli amministratori
- file sotto embargo
- nessun file disponibile